MilliporeSigma Awarded Canadian CRISPR Nickase Patent for Foundational Genome-Editing Technology PRNewswire
Patent covers paired Cas9 nickase technology to advance gene therapy and research, reduce off-target effects – Marks MilliporeSigma’s 13th CRISPR patent…